Investigation Overview
After HealthTronics Inc. announced to be acquired by Endo Pharmaceuticals Holdings Inc. an investigation on behalf of current investors in HealthTronics Inc. (NASDAQ:HTRN) concerning shareholder claims over possible breaches of fiduciary duty was announced. The investigation by a law firm focuses on potential breaches of fiduciary duty and other violations of state law by the Board o...
You must register (for free) or login to view the entire investigation.